Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study

Por Fathi, Amir T., DiNardo, Courtney D., Kline, Irina, Kenvin, Laurie, Gupta, Ira, Attar, Eyal C., Stein, Eytan M., de Botton, Stephane
Publicado no JAMA Oncol (2018)

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide

Por Rollison, Dana E., Shain, Kenneth H., Lee, Ji‐Hyun, Hampras, Shalaka S., Fulp, William, Fisher, Kate, Al Ali, Najla H., Padron, Eric, Lancet, Jeffrey, Xu, Qiang, Olesnyckyj, Martha, Kenvin, Laurie, Knight, Robert, Dalton, William, List, Alan, Komrokji, Rami S.
Publicado no Cancer Med (2016)